https://www.thebodypro.com/category/fda-approved-hiv-medications/tag/women

The Latest

Fernanda Fernandes Fonseca and Meg Doherty at an IAS 2019 press conference

World Health Organization Updates Guidance on Dolutegravir After Reassuring Data Regarding Safety in Early Pregnancy

New study results leave many experts feeling they went too far in their concerns over birth defect risks associated with the drug.

Putting test tubes into the holder

This Week in HIV Research: I Screen, You Screen, We All Screen for HPV-Related Cancers

May 23, 2019: How CD4 variables over time affect anal cancer risk; when to consider anal pap smears for women; switching from E/C/F/TAF to ABC/3TC; new data on marijuana use among people with HIV.

Efavirenz Might Decrease Effectiveness of the Vaginal Contraceptive Ring Img

Efavirenz Might Decrease Effectiveness of the Vaginal Contraceptive Ring

Efavirenz (Sustiva, Stocrin) alters hormone exposure from the vaginal ring in HIV positive women, similar or greater to that previously reported with oral hormonal contraceptives.

Promo Image

Late 2017 HIV Conferences Focus on Antiretrovirals and Comorbidities

2017 may be winding down, but even as the year wanes, we’ve seen significant new HIV research featured in major scientific conferences in the U.S. and Europe. IDWeek, most recently held in San Diego in early October 2017, is an annual infectious disease...

Promo Image

Women and HIV: Hormonal Contraception for HIV Positive Women

For women who are living with HIV, avoiding pregnancy (or the side effects of severe periods) may not be as easy as popping a birth control pill. As this article from the San Francisco AIDS Foundation details, the use of hormonal contraceptives can r...

Promo Image

Women and Pharmacology

There are known and potential considerations for women with regard to how drugs are processed in the body, a field of study called pharmacology. Studies describing some of these note sex differences in metabolism, drug levels, and/or side effects. Th...